Report of Foreign Issuer (6-k)
September 17 2019 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For the month of
September 2019
Commission File Number: 001-39034
BELLUS Health Inc.
(Name of registrant)
275 Armand-Frappier Blvd.
Laval, Quebec
H7V 4A7 Canada
(Address of principal
executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BELLUS Health Inc.
|
|
|
|
|
Date: September 17, 2019
|
By:
|
/s/ Francois Desjardins
|
|
|
|
Name:
|
Francois Desjardins
|
|
|
|
Title:
|
Vice President, Finance
|
|
Form 6-K Exhibit Index
Exhibit
Number
|
|
Document Description
|
99.1
|
|
Material Change Report dated September 13, 2019.
|